CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Option exercise Director acquired 56,361 shares (option exercise)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 4 Open-market sale Director sold 8,668 shares at $8.00 ($69,344)
- 144 Insider Sale of Securities
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale Director sold 80,000 shares at $8.30 ($664,000)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale 10% owner sold 5,000,000 shares at $8.35 ($41,750,000)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
Page 7 of 35 · 695 filings